Key Market Indicators
Sales of antihypertensive medicines in Spain are expected to reach $200 million by 2026. In 2021, the country was the third-largest market, with sales of $167 million. This represents an annual growth rate of 3.2% since 2009, when the market was valued at $125 million. Italy overtook Spain as the second-biggest market in 2021. Italy, Spain and Australia were the second, third and fourth largest markets, respectively.
